Loading...

PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg 72 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg 183 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  2. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  3. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  4. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  5. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  6. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  7. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  8. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  9. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  10. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  11. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  12. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  13. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  14. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  15. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  16. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  17. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  18. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  19. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  20. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  21. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  22. Bussey KA, et al. 2019. J Virol. 93. PubMed
  23. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  24. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  25. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  26. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  27. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  28. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  29. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  30. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  31. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  32. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  33. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  34. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  35. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  36. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  37. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  38. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  39. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  40. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  41. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  42. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  43. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  44. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  45. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  46. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  47. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  48. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  49. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  50. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  51. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  52. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  53. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  54. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  55. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  56. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  57. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  58. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  59. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  60. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  61. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  62. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  63. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  64. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  65. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  66. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  67. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  68. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  69. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  70. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  71. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  72. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  73. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  74. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  75. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  76. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  77. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  78. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  79. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  80. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  81. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  82. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  83. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  84. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  85. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  86. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  87. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  88. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  89. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  90. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  91. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  92. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  93. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  94. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  95. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  96. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  97. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  98. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  99. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  100. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  101. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  102. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  103. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  104. De Simone G, et al. 2021. Immunity. :. PubMed
  105. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  106. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  107. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  108. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  109. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  110. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  111. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  112. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  113. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  114. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  115. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  116. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  117. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  118. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  119. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  121. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  122. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  123. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  124. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  125. Gu H, et al. 2021. Elife. 10:. PubMed
  126. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  127. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  128. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  129. Vorselen D, et al. 2021. Elife. 10:. PubMed
  130. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  131. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  132. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  133. Jones GS, et al. 2020. mSphere. 5:. PubMed
  134. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  135. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  136. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  137. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  138. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  139. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  140. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  141. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  142. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  143. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  144. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  145. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  146. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  147. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  148. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  151. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  152. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  153. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  154. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  155. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  156. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  157. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  158. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  159. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  160. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  161. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  162. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  163. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  164. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  165. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  166. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  167. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  168. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  169. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  170. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  171. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  172. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  173. Guo R, et al. 2022. Cells. 12: . PubMed
  174. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  175. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  176. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  177. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  178. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  179. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  180. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  181. Boroumand P, et al. 2022. Elife. 11:. PubMed
  182. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  183. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  184. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  185. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  186. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  187. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  188. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  189. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  190. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  191. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  192. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11.30.2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account